Translational Development Acquisition Corp. (TDAC) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 Michael Hoffman.
TDAC 을(를) 보유 IPO 날짜 2025-02-20, 2 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $232.22M.
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
